T2 Biosystems
T2 Biosystems is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
About T2 Biosystems
T2 Biosystems is a startup based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
T2 Biosystems is a medical diagnostics company that develops and commercializes instruments and molecular diagnostic panels, including the T2Dx instrument and T2Candida and T2Bacteria panels, to enable rapid detection of bloodstream infections and other pathogens. The company also maintains a pipeline of sepsis management products and panels for bacterial resistance and Lyme disease.
Explore T2 Biosystems's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.